United States · FDA National Drug Code directory

Phenazopyridine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-813_e018e176-c4ec-42a2-9119-f1278cfa719a
Product NDC
71205-813
Form
TABLET
Composition / generic term
Phenazopyridine
Labeler
Proficient Rx LP
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20110201
Source listing expiry
20261231

Source-listed ingredients

  • PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 TABLET in 1 BOTTLE (71205-813-06) · 71205-813-06
  • 10 TABLET in 1 BOTTLE (71205-813-10) · 71205-813-10
  • 12 TABLET in 1 BOTTLE (71205-813-12) · 71205-813-12
  • 20 TABLET in 1 BOTTLE (71205-813-20) · 71205-813-20
  • 24 TABLET in 1 BOTTLE (71205-813-24) · 71205-813-24
  • 30 TABLET in 1 BOTTLE (71205-813-30) · 71205-813-30
  • 60 TABLET in 1 BOTTLE (71205-813-60) · 71205-813-60
  • 90 TABLET in 1 BOTTLE (71205-813-90) · 71205-813-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →